FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, specifically to a compound of formula (I):
, where R1 is halogen; R2 is phenyl, where R2 is optionally substituted with R2a from one to five; R2a is selected from H or halogen; R3 is C1-4 alkyl; R4 is H; R5 is cyano; R6 is selected from amino or alkyl, and R7 is selected from H or amino; wherein any hydrogen atom in the compound of formula (I) can be deuterium. Also disclosed is a pharmaceutical composition, use and a method of producing a compound of formula (I).
EFFECT: technical result is obtaining novel compounds which can be used to inhibit lipid kinase activity PI3K.
9 cl, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | 2014 |
|
RU2675105C9 |
SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | 2014 |
|
RU2683793C2 |
PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF | 2016 |
|
RU2735522C2 |
BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
HETEROARYL DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A METHOD FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAID ACTIVE SUBSTANCE | 2016 |
|
RU2719367C2 |
COMPOUNDS WITH SPIRO AND AROMATIC RINGS AND APPLICATION THEREOF | 2019 |
|
RU2781100C1 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
NOVEL HYDROXY-ESTER DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2734418C2 |
Authors
Dates
2020-07-09—Published
2017-10-18—Filed